To test whether co-treatment with tamoxifen and DCA inhibits breast cancer stem-like cells, we performed flow cytometry analysis to estimate the proportion of stem-like cell subpopulation in MCF7 cells based on the expression CD44. The gene discussed is CD44; the disease is breast cancer.